Sunny Zhang

Sunny Zhang is a seasoned pharmaceutical development professional with extensive experience in biologics drug product process development and manufacturing. Currently serving as Senior Director of Pharmaceutical Development at ADC Therapeutics since 2022, Sunny previously held significant roles at WuXi Biologics and Amgen, leading cross-functional project teams, managing CMO partnerships, and overseeing technology transfers and regulatory filings. With a strong technical background developed through positions at RZN Biotechnology Co., Ltd, Amgen, and Abgenix, Sunny has successfully directed formulation and analytical method development, contributing to commercial launches and ensuring compliance with regulatory standards. Educational credentials include a Master of Science in Chemical Engineering from the University at Buffalo and a Master of Science in Computer Engineering from Santa Clara University, complemented by a Bachelor's degree in Biochemical Engineering from South China University of Technology.